U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C18H30N2O2
Molecular Weight 306.443
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUTACAINE

SMILES

CCCCN(CCCC)CCCOC(=O)C1=CC=C(N)C=C1

InChI

InChIKey=HQFWVSGBVLEQGA-UHFFFAOYSA-N
InChI=1S/C18H30N2O2/c1-3-5-12-20(13-6-4-2)14-7-15-22-18(21)16-8-10-17(19)11-9-16/h8-11H,3-7,12-15,19H2,1-2H3

HIDE SMILES / InChI

Description

Butacaine is a local anesthetic. It should not be used with people who have a history of allergies due to the possibility of anaphylactic shock.

Originator

Abbott
94

Approval Year

1920
2

Conditions

ConditionModalityTargetsHighest PhaseProduct

PubMed

Patents

JP2007195974A
8
JP2011513484A
29

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
The specific activities of two transferases, aspartate-amino-transferase and creatine phosphokinase, are increased by 10(-5) mol/l butacaine
ACTIVE MOIETY
Structure of BUTACAINE
SALT/SOLVATE (PARENT)
Structure of BUTACAINE SULFATE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966